Background: Understanding and managing speech problems in patients with 22q11.2 deletion syndrome (22q11DS) is especially challenging because many clinical findings are associated with the syndrome and the presentation is heterogeneous among patients. Naturally, parents are interested to know whether their child will benefit from surgery. However, prognostic factors remain elusive. Since the individual outcome is variable and difficult to predict, there is often disappointment. Our objectives were to increase the understanding of the etiology of velopharyngeal dysfunction (VPD) in 22q11DS and find prognostic factors for outcome. Methods and Results: Histological properties of the pharyngeal constrictor muscle did not differ between patients...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....
22q11.2 Deletion Syndrome (22q) is the most common microdeletion known in humans. Studies have hypot...
OBJECTIVE: To investigate the clinical manifestations at diagnosis and during follow-up in patients ...
Background: Understanding and managing speech problems in patients with 22q11.2 deletion syndrome (2...
Aim: To find out if subjects with 22q11.2 deletion syndrome (DS) have a different velopharyngeal ana...
Patients with the 22q11.2 deletion syndrome (22qDS) and velopharyngeal dysfunction (VPD) tend to hav...
Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a ve...
Objective: To describe the effect of time after velopharyngoplasty on outcome and to search for preo...
Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a ve...
Abstract Objective To identify and describe the dynamic features of velopharyngeal dysfunction (VPD)...
22q11.2 deletion syndrome is the most common genetic cause of velopharyngeal dysfunction. Studies ex...
Objective: To identify and describe the dynamic features of velopharyngeal dysfunction (VPD) in pati...
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with s...
Aims: To study speech with regard to articulation and perceptual speech symptoms related to velophar...
Speech anomalies have been described as characteristic symptoms for the 22q11 deletion syndrome. How...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....
22q11.2 Deletion Syndrome (22q) is the most common microdeletion known in humans. Studies have hypot...
OBJECTIVE: To investigate the clinical manifestations at diagnosis and during follow-up in patients ...
Background: Understanding and managing speech problems in patients with 22q11.2 deletion syndrome (2...
Aim: To find out if subjects with 22q11.2 deletion syndrome (DS) have a different velopharyngeal ana...
Patients with the 22q11.2 deletion syndrome (22qDS) and velopharyngeal dysfunction (VPD) tend to hav...
Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a ve...
Objective: To describe the effect of time after velopharyngoplasty on outcome and to search for preo...
Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a ve...
Abstract Objective To identify and describe the dynamic features of velopharyngeal dysfunction (VPD)...
22q11.2 deletion syndrome is the most common genetic cause of velopharyngeal dysfunction. Studies ex...
Objective: To identify and describe the dynamic features of velopharyngeal dysfunction (VPD) in pati...
Background: 22q11.2DS is the most common microdeletion syndrome in humans, usually associated with s...
Aims: To study speech with regard to articulation and perceptual speech symptoms related to velophar...
Speech anomalies have been described as characteristic symptoms for the 22q11 deletion syndrome. How...
To investigate the clinical manifestations at diagnosis and during follow-up in patients with 22q11....
22q11.2 Deletion Syndrome (22q) is the most common microdeletion known in humans. Studies have hypot...
OBJECTIVE: To investigate the clinical manifestations at diagnosis and during follow-up in patients ...